Found 5 matching trials
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter PHASE2 This is a randomized, open-label, phase 2 study evaluating the safety and e...
Show More Location
Lombardi Comprehensive Cancer Center
Learn More & Join Trial
Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases PHASE1 This phase I trial studies the side effects and best dose of ropidoxuridine...
Show More Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas PHASE1 Background:
\- The experimental drug IPdR is broken down in the body to Id...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer PHASE1 This phase I trial studies the side effects and best dose of ropidoxuridine...
Show More Location
Los Angeles County-USC Medical Center
Learn More & Join Trial
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy PHASE1 This phase I trial studies the side effects and best dose of ropidoxuridine...
Show More Status
Active Not Recruiting
Location
Rhode Island Hospital
Learn More & Join Trial